Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 13 Breast Neoplasms 13 Colorectal Neoplasms 8 Obesity 7 Ovarian Neoplasms 6 Motor Activity 5 Malnutrition 5 Rectal Neoplasms 4 Polycystic Ovary Syndrome 4 Pancreatic Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Radiation Injuries 3 Overweight 3 Multiple Myeloma 3 Melanoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Weight Loss 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Glioblastoma 2

Interventions

pembrolizumab 180 Gemcitabine 168 Paclitaxel 150 Carboplatin 134 Bevacizumab 126 Cisplatin 113 Docetaxel 112 Cyclophosphamide 109 Exercise 97 Nivolumab 92 Fluorouracil 88 Capecitabine 85 Dexamethasone 81 Irinotecan 74 Radiotherapy 68 Oxaliplatin 68 Pemetrexed 66 Standard of Care 64 Leucovorin 63 Cetuximab 59 Sorafenib 53 Erlotinib Hydrochloride 53 Drug Therapy 53 Blood Specimen Collection 52 Doxorubicin 50 trametinib 47 atezolizumab 47 Ipilimumab 47 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Diet Therapy × Clear all

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡